Endocannabinoids and the FAAH polymorphism

Last updated date

12:13pm

Using a vertically integrated approach in parallel mouse-human studies to we have analyzed a common human genetic variant in the endocannabinoid system, which highlights the capacity to study molecular defects in plasticity genes, and link them to circuit-level and behavioral phenotypes. We developed a knock-in mouse that biologically recapitulates a common human mutation in the gene for fatty acid amide hydrolase (FAAH) (C385A; rs324420), the primary catabolic enzyme for the endocannabinoid anandamide. This common polymorphism impacts the expression and activity of FAAH, thereby increasing anandamide levels. We have shown that the genetic knock-in mouse and human variant allele carriers exhibit parallel alterations in biochemistry, neurocircuitry, and behavior. Specifically, there is reduced FAAH expression associated with the variant allele that selectively enhances fronto-amygdala connectivity and fear extinction learning, and decreases anxiety-like behaviors. These findings bridge an important translational gap between the mouse and human.

Endocannabinoids and the FAAH polymorphism

Weill Cornell Medicine Dr. Francis S. Lee Lab 1300 York Avenue, Box 244 New York, NY 10065 Phone: (212) 746-5403